Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Pulmonx | LUNG | Sep 25, 2024 | 8.25 | -1.20 |
Pulse Biosciences | PLSE | Sep 25, 2024 | 16.93 | -1.23 |
PulteGroup | PHM | Sep 25, 2024 | 140.46 | -1.95 |
Puma Biotechnology | PBYI | Sep 25, 2024 | 2.55 | 0.00 |
Pure Cycle | PCYO | Sep 25, 2024 | 10.45 | -2.06 |
Pure Storage A | PSTG | Sep 25, 2024 | 50.42 | +1.22 |
PureCycle Technologies | PCT | Sep 25, 2024 | 9.70 | -4.62 |
PureCycle Technologies Unit | PCTTU | Sep 25, 2024 | 12.00 | +11.11 |
Purefunds ISE Junior Silver [Sm | SILJ | Sep 25, 2024 | 13.45 | -0.15 |
PureTech Health ADR | PRTC | Sep 25, 2024 | 20.04 | +2.87 |
Purple Biotech ADR | PPBT | Sep 25, 2024 | 5.64 | -5.92 |
Purple Innovation | PRPL | Sep 25, 2024 | 1.02 | -4.67 |
Putnam Managed Municipal Income Trust | PMM | Sep 25, 2024 | 6.46 | -0.15 |
Putnam Master Intermediate Income Trust | PIM | Sep 25, 2024 | 3.39 | -1.74 |
Putnam Municipal Opportunities Trust | PMO | Sep 25, 2024 | 10.79 | +0.09 |
Putnam Premier Income Trust | PPT | Sep 25, 2024 | 3.69 | -0.54 |
PVH | PVH | Sep 25, 2024 | 94.99 | -1.10 |
Pyrophyte Acquisition | PHYT | Sep 25, 2024 | 11.51 | 0.00 |
Pyxis Oncology | PYXS | Sep 25, 2024 | 3.51 | -2.50 |
Pyxis Tankers | PXS | Sep 25, 2024 | 5.05 | -0.79 |
Pyxis Tankers Pref | PXSAP | Sep 25, 2024 | 25.08 | +0.16 |
Q2 | QTWO | Sep 25, 2024 | 78.29 | -0.25 |
Q32 Bio | QTTB | Sep 25, 2024 | 44.40 | +0.07 |
QCR | QCRH | Sep 25, 2024 | 72.85 | -1.77 |
QIAGEN | QGEN | Sep 25, 2024 | 44.11 | -1.67 |
Qifu Technology ADR | QFIN | Sep 25, 2024 | 26.69 | -3.23 |
Qilian International | BGM | Sep 25, 2024 | 7.70 | 0.00 |
Qilian International | QLI | Sep 25, 2024 | 5.41 | 0.00 |
QMMM | QMMM | Sep 25, 2024 | 6.32 | 0.00 |
Qomolangma Acquisition | QOMO | Sep 25, 2024 | 11.60 | -0.85 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.